The Duckhorn Portfolio Announces Second Quarter 2023 Financial Results
The Duckhorn Portfolio reported a net sales increase of $103.5 million for Q2 2023, up 4.8% year-over-year. Gross profit also rose to $55.2 million, achieving a margin of 53.3%, an improvement of 320 basis points. Net income was $14.9 million, down from $17.9 million in Q2 2022, while adjusted net income climbed to $21.1 million. Adjusted EBITDA reached $38.8 million, reflecting a 13.1% increase. The company raised its fiscal 2023 guidance for net sales to $398-$404 million, adjusted EBITDA to $135-$138 million, and adjusted EPS to $0.63-$0.65.
- Net sales increased by $4.8 million, or 4.8%, year-over-year.
- Gross profit rose by $5.7 million, or 11.5%, with a gross profit margin of 53.3%.
- Adjusted EBITDA grew to $38.8 million, a 13.1% increase from the previous year.
- Raising FY 2023 guidance for net sales to $398-$404 million and adjusted EBITDA to $135-$138 million.
- Net income decreased to $14.9 million from $17.9 million in the prior year period.
- Selling, general and administrative expenses rose significantly by 24% to $29.6 million.
Net Income of
Adjusted EBITDA of
Raises Fiscal Year 2023 Net Sales, Adjusted EBITDA and Adjusted EPS Guidance
Second Quarter 2023 Highlights
-
Net sales were
, an increase of$103.5 million , or$4.8 million 4.8% , versus the prior year period. -
Gross profit was
, an increase of$55.2 million , or$5.7 million 11.5% , versus the prior year period. Gross profit margin was53.3% , up 320 basis points versus the prior year period. Adjusted gross profit was , an increase of$55.5 million , or$5.7 million 11.6% , versus the prior year period. Adjusted gross profit margin was53.6% , up 320 basis points versus the prior year period. -
Net income was
, or$14.9 million per diluted share, versus$0.13 , or$17.9 million per diluted share, in the prior year period. Adjusted net income was$0.16 , or$21.1 million per diluted share, versus$0.18 , or$19.5 million per diluted share, in the prior year period.$0.17 -
Adjusted EBITDA was
, an increase of$38.8 million , or$4.5 million 13.1% , and margin increased 280 basis points versus the prior year period. -
Cash was
as of$7.3 million January 31, 2023 . The Company’s leverage ratio was 1.7x net debt (net of deferred financing costs), to trailing twelve months adjusted EBITDA.
“Our second quarter results are a testament to the successful execution of our growth strategy as we continue to consistently take share and outperform our peers in the high growth luxury subsegment of the wine industry,” commented
Ryan continued, “On the back of another strong quarter, we are raising and tightening the ranges of our Fiscal 2023 net sales, adjusted EBITDA and adjusted EPS guidance. We have a proven track record of delivering profitable, sustainable growth and remain confident in reaching our upwardly revised financial guidance in 2023 and maximizing shareholder value in the years to come.”
Second Quarter 2023 Results
|
Three months ended |
|||||
|
2023 |
|
2022 |
|||
Net sales growth |
4.8 |
% |
|
18.0 |
% |
|
Volume contribution |
(0.4 |
)% |
|
24.8 |
% |
|
Price / mix contribution |
5.2 |
% |
|
(6.8 |
)% |
|
|
Three months ended |
|||||
|
2023 |
|
2022 |
|||
Wholesale – Distributors |
61.3 |
% |
|
67.2 |
% |
|
Wholesale – |
19.1 |
|
|
19.8 |
|
|
DTC |
19.6 |
|
|
13.0 |
|
|
Net sales |
100.0 |
% |
|
100.0 |
% |
Net sales were
Gross profit was
Total selling, general and administrative expenses were
Net income was
Adjusted EBITDA was
Fiscal Year 2023 Guidance
The Company is raising its previously provided fiscal 2023 guidance.
The Company’s upwardly revised guidance ranges are presented below for fiscal year 2023:
(amounts in millions, except per share data and percentages) |
Fiscal year ended
|
|||
Net sales |
|
- |
|
|
Adjusted EBITDA |
|
- |
|
|
Adjusted EPS |
|
- |
|
|
Diluted share count |
115 |
- |
116 |
|
Effective tax rate |
|
- |
|
Conference Call and Webcast
The Company will host a conference call and webcast today to discuss these results at
About
Use of Non-GAAP Financial Information
In addition to the Company’s results, which are determined in accordance with generally accepted accounting principles in
Forward-Looking Statements
This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. These forward-looking statements address various matters including statements regarding the timing or nature of future operating or financial performance or other events. For example, all statements
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, amounts in thousands, except shares and per share data) |
||||||
|
|
|
|
|||
ASSETS |
|
|
|
|||
Current assets |
|
|
|
|||
Cash |
$ |
7,292 |
|
$ |
3,167 |
|
Accounts receivable trade, net |
|
48,324 |
|
|
37,026 |
|
Inventories |
|
327,024 |
|
|
285,430 |
|
Prepaid expenses and other current assets |
|
13,125 |
|
|
13,898 |
|
Total current assets |
|
395,765 |
|
|
339,521 |
|
Long-term assets |
|
|
|
|||
Property and equipment, net |
|
271,217 |
|
|
269,659 |
|
Operating lease right-of-use assets |
|
21,777 |
|
|
23,375 |
|
Intangible assets, net |
|
188,006 |
|
|
191,786 |
|
|
|
425,209 |
|
|
425,209 |
|
Other long-term assets |
|
5,487 |
|
|
1,963 |
|
Total long-term assets |
|
911,696 |
|
|
911,992 |
|
Total assets |
$ |
1,307,461 |
|
$ |
1,251,513 |
|
LIABILITIES AND EQUITY |
||||||
Current liabilities |
|
|
|
|||
Accounts payable |
$ |
18,410 |
|
$ |
3,382 |
|
Accrued expenses |
|
29,071 |
|
|
29,475 |
|
Accrued compensation |
|
9,224 |
|
|
12,893 |
|
Deferred revenue |
|
3,285 |
|
|
272 |
|
Current operating lease liabilities |
|
3,603 |
|
|
3,498 |
|
Current maturities of long-term debt |
|
9,721 |
|
|
9,810 |
|
Other current liabilities |
|
3,056 |
|
|
672 |
|
Total current liabilities |
|
76,370 |
|
|
60,002 |
|
Long-term liabilities |
|
|
|
|||
Revolving line of credit, net |
|
— |
|
|
108,674 |
|
Long-term debt, net of current maturities and debt issuance costs |
|
215,633 |
|
|
105,074 |
|
Operating lease liabilities |
|
18,000 |
|
|
19,732 |
|
Derivative instrument |
|
1,537 |
|
|
— |
|
Deferred income taxes |
|
90,483 |
|
|
90,483 |
|
Other long-term liabilities |
|
387 |
|
|
387 |
|
Total long-term liabilities |
|
326,040 |
|
|
324,350 |
|
Total liabilities |
|
402,410 |
|
|
384,352 |
|
Equity |
|
|
|
|||
Common stock, |
|
1,152 |
|
|
1,152 |
|
Additional paid-in capital |
|
734,763 |
|
|
731,597 |
|
Retained earnings |
|
168,556 |
|
|
133,824 |
|
Total |
|
904,471 |
|
|
866,573 |
|
Non-controlling interest |
|
580 |
|
|
588 |
|
Total equity |
|
905,051 |
|
|
867,161 |
|
Total liabilities and equity |
$ |
1,307,461 |
|
$ |
1,251,513 |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, amounts in thousands, except shares and per share data) |
||||||||||||||
|
Three months ended
|
|
Six months ended
|
|||||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|||||||
Net sales (net of excise taxes of |
$ |
103,488 |
|
$ |
98,736 |
|
|
$ |
211,659 |
|
$ |
202,917 |
|
|
Cost of sales |
|
48,302 |
|
|
49,259 |
|
|
|
101,763 |
|
|
101,030 |
|
|
Gross profit |
|
55,186 |
|
|
49,477 |
|
|
|
109,896 |
|
|
101,887 |
|
|
|
|
|
|
|
|
|
|
|||||||
Selling, general and administrative expenses |
|
29,579 |
|
|
23,845 |
|
|
|
55,318 |
|
|
47,052 |
|
|
Income from operations |
|
25,607 |
|
|
25,632 |
|
|
|
54,578 |
|
|
54,835 |
|
|
|
|
|
|
|
|
|
|
|||||||
Interest expense |
|
2,684 |
|
|
1,636 |
|
|
|
4,846 |
|
|
3,242 |
|
|
Other expense (income), net |
|
2,743 |
|
|
(338 |
) |
|
|
2,656 |
|
|
(1,431 |
) |
|
Total other expenses, net |
|
5,427 |
|
|
1,298 |
|
|
|
7,502 |
|
|
1,811 |
|
|
Income before income taxes |
|
20,180 |
|
|
24,334 |
|
|
|
47,076 |
|
|
53,024 |
|
|
Income tax expense |
|
5,265 |
|
|
6,407 |
|
|
|
12,352 |
|
|
13,784 |
|
|
Net income |
|
14,915 |
|
|
17,927 |
|
|
|
34,724 |
|
|
39,240 |
|
|
Less: Net loss (income) attributable to non-controlling interest |
|
2 |
|
|
5 |
|
|
|
8 |
|
|
(35 |
) |
|
Net income attributable to |
$ |
14,917 |
|
$ |
17,932 |
|
|
$ |
34,732 |
|
$ |
39,205 |
|
|
|
|
|
|
|
|
|
|
|||||||
Net income per share of common stock: |
|
|
|
|
|
|
|
|||||||
Basic |
$ |
0.13 |
|
$ |
0.16 |
|
|
$ |
0.30 |
|
$ |
0.34 |
|
|
Diluted |
$ |
0.13 |
|
$ |
0.16 |
|
|
$ |
0.30 |
|
$ |
0.34 |
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted average shares of common stock outstanding: |
|
|
|
|
|
|
|
|||||||
Basic |
|
115,191,575 |
|
|
115,049,395 |
|
|
|
115,187,868 |
|
|
115,048,094 |
|
|
Diluted |
|
115,327,660 |
|
|
115,389,502 |
|
|
|
115,424,809 |
|
|
115,391,011 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, amounts in thousands) |
||||||||
|
Six months ended |
|||||||
|
2023 |
|
2022 |
|||||
Cash flows from operating activities |
|
|
|
|||||
Net income |
$ |
34,724 |
|
|
$ |
39,240 |
|
|
Adjustments to reconcile net income to net cash from operating activities: |
|
|
|
|||||
Depreciation and amortization |
|
13,290 |
|
|
|
11,047 |
|
|
Loss (gain) on disposal of assets |
|
93 |
|
|
|
(13 |
) |
|
Change in fair value of derivatives |
|
2,061 |
|
|
|
(957 |
) |
|
Amortization of debt issuance costs |
|
593 |
|
|
|
804 |
|
|
Equity-based compensation |
|
2,985 |
|
|
|
2,875 |
|
|
Change in operating assets and liabilities: |
|
|
|
|||||
Accounts receivable trade, net |
|
(11,298 |
) |
|
|
(9,755 |
) |
|
Inventories |
|
(39,881 |
) |
|
|
(28,187 |
) |
|
Prepaid expenses and other current assets |
|
26 |
|
|
|
(361 |
) |
|
Other long-term assets |
|
(555 |
) |
|
|
(217 |
) |
|
Accounts payable |
|
15,020 |
|
|
|
6,377 |
|
|
Accrued expenses |
|
830 |
|
|
|
6,621 |
|
|
Accrued compensation |
|
(3,669 |
) |
|
|
(4,129 |
) |
|
Deferred revenue |
|
3,013 |
|
|
|
(2,960 |
) |
|
Other current and long-term liabilities |
|
865 |
|
|
|
(1,557 |
) |
|
Net cash provided by operating activities |
|
18,097 |
|
|
|
18,828 |
|
|
Cash flows from investing activities |
|
|
|
|||||
Purchases of property and equipment, net of sales proceeds |
|
(12,388 |
) |
|
|
(23,336 |
) |
|
Net cash used in investing activities |
|
(12,388 |
) |
|
|
(23,336 |
) |
|
Cash flows from financing activities |
|
|
|
|||||
Payments under line of credit |
|
(119,000 |
) |
|
|
(52,000 |
) |
|
Borrowings under line of credit |
|
9,000 |
|
|
|
63,000 |
|
|
Issuance of long-term debt |
|
225,833 |
|
|
|
— |
|
|
Payments of long-term debt |
|
(115,166 |
) |
|
|
(5,696 |
) |
|
Proceeds from employee stock purchase plan |
|
181 |
|
|
|
— |
|
|
Payments for debt issuance costs |
|
(2,432 |
) |
|
|
— |
|
|
Payments of deferred offering costs |
|
— |
|
|
|
(270 |
) |
|
Net cash (used in) provided by financing activities |
|
(1,584 |
) |
|
|
5,034 |
|
|
Net increase in cash |
|
4,125 |
|
|
|
526 |
|
|
Cash - Beginning of period |
|
3,167 |
|
|
|
4,244 |
|
|
Cash - End of period |
$ |
7,292 |
|
|
$ |
4,770 |
|
|
Supplemental cash-flow information |
|
|
|
|||||
Interest paid, net of amount capitalized |
$ |
1,649 |
|
|
$ |
2,479 |
|
|
Income taxes paid |
$ |
10,621 |
|
|
$ |
8,014 |
|
|
Non-cash investing activities |
|
|
|
|||||
Property and equipment additions in accounts payable and accrued expenses |
$ |
467 |
|
|
$ |
193 |
|
|
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
Adjusted gross profit, adjusted net income, adjusted EBITDA and adjusted EPS, collectively referred to as “Non-GAAP Financial Measures,” are commonly used in the Company’s industry and should not be construed as an alternative to net income or earnings per share as indicators of operating performance (as determined in accordance with GAAP). These Non-GAAP Financial Measures may not be comparable to similarly titled measures reported by other companies. The Company has included these Non-GAAP Financial Measures because it believes the measures provide management and investors with additional information to evaluate business performance in comparison to budgets, forecasts and prior year financial results.
Non-GAAP Financial Measures are adjusted to exclude certain items that affect comparability. The adjustments are itemized in the tables below. You are encouraged to evaluate these adjustments and the reason the Company considers them appropriate for supplemental analysis. In evaluating adjustments, you should be aware that in the future the Company may incur expenses that are the same as or similar to some of the adjustments set forth below. The presentation of Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or recurring items.
Adjusted EBITDA
Adjusted EBITDA is a non-GAAP financial measure that the Company calculates as net income before interest, taxes, depreciation and amortization, non-cash equity-based compensation expense, purchase accounting adjustments, casualty losses or gains, changes in the fair value of derivatives and certain other items which are not related to our core operating performance. Adjusted EBITDA is a key performance measure the Company uses in evaluating its operational results. The Company believes adjusted EBITDA is a helpful measure to provide investors an understanding of how management regularly monitors the Company’s core operating performance, as well as how management makes operational and strategic decisions in allocating resources. The Company believes adjusted EBITDA also provides management and investors consistency and comparability with the Company’s past financial performance and facilitates period to period comparisons of operations, as it eliminates the effects of certain variations unrelated to its overall performance.
Adjusted EBITDA has certain limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Some of these limitations include:
- although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
- adjusted EBITDA does not reflect changes in, or cash requirements for, the Company’s working capital needs;
- adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments, on the Company’s debt;
- adjusted EBITDA does not reflect income tax payments that may represent a reduction in cash available to the Company; and
- other companies, including companies in the Company’s industry, may calculate adjusted EBITDA differently, which reduce their usefulness as comparative measures.
Because of these limitations, you should consider adjusted EBITDA alongside other financial performance measures, including net income and the Company’s other GAAP results. In evaluating adjusted EBITDA, you should be aware that in the future the Company may incur expenses that are the same as or similar to some of the adjustments in this presentation. The Company’s presentation of adjusted EBITDA should not be construed as an inference that the Company’s future results will be unaffected by the types of items excluded from the calculation of adjusted EBITDA.
Adjusted Gross Profit
Adjusted gross profit is a non-GAAP financial measure that the Company calculates as gross profit excluding the impact of purchase accounting adjustments (including depreciation and amortization related to purchase accounting), non-cash equity-based compensation expense and certain inventory charges. We believe adjusted gross profit is a useful measure to us and our investors to assist in evaluating our operating performance because it provides consistency and direct comparability with our past financial performance between fiscal periods, as the metric eliminates the effects of non-cash or other expenses unrelated to our core operating performance that would result in fluctuations in a given metric for reasons unrelated to overall continuing operating performance. Adjusted gross profit should not be considered a substitute for gross profit or any other measure of financial performance reported in accordance with GAAP.
Adjusted Net Income
Adjusted net income is a non-GAAP financial measure that the Company calculates as net income excluding the impact of non-cash equity-based compensation expense, purchase accounting adjustments, casualty losses or gains, impairment losses (including certain inventory charges), changes in the fair value of derivatives and certain other items unrelated to core operating performance, as well as the estimated income tax impacts of all such adjustments included in this non-GAAP performance measure. We believe adjusted net income assists us and our investors in evaluating our performance period-over-period. In calculating adjusted net income, we also calculate the following non-GAAP financial measures which adjust each GAAP-based financial measure for the relevant portion of each adjustment to reach adjusted net income:
- Adjusted SG&A – calculated as selling, general, and administrative expenses excluding the impacts of purchase accounting, transaction expenses and equity-based compensation; and
- Adjusted income tax – calculated as the tax effect of all adjustments to reach adjusted net income based on the applicable blended statutory tax rate for the period.
Adjusted net income should not be considered a substitute for net income or any other measure of financial performance reported in accordance with GAAP.
Adjusted EPS
Adjusted EPS is a non-GAAP financial measure that the Company calculates as adjusted net income divided by diluted share count for the applicable period. We believe adjusted EPS is useful to us and our investors because it improves the comparability of results of operations from period to period. Adjusted EPS should not be considered a substitute for net income per share or any other measure of financial performance reported in accordance with GAAP.
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES |
||||||||||||||||||||||||||
Three months ended (Unaudited, amounts in thousands, except shares and per share data) |
||||||||||||||||||||||||||
|
Three months ended |
|||||||||||||||||||||||||
|
Net sales |
|
Gross profit |
|
SG&A |
|
Adjusted EBITDA |
|
Income tax |
|
Net income |
|
Diluted EPS |
|||||||||||||
GAAP results |
$ |
103,488 |
|
$ |
55,186 |
|
|
$ |
29,579 |
|
|
$ |
14,917 |
|
|
$ |
5,265 |
|
|
$ |
14,917 |
|
|
$ |
0.13 |
|
Percentage of net sales |
|
|
|
53.3 |
% |
|
|
28.6 |
% |
|
|
14.4 |
% |
|
|
|
|
|
|
|||||||
Interest expense |
|
|
|
|
|
|
|
2,684 |
|
|
|
|
|
|
|
|||||||||||
Income tax expense |
|
|
|
|
|
|
|
5,265 |
|
|
|
|
|
|
|
|||||||||||
Depreciation and amortization expense |
|
|
|
116 |
|
|
|
(1,904 |
) |
|
|
7,533 |
|
|
|
|
|
|
|
|||||||
EBITDA |
|
|
|
|
|
|
$ |
30,399 |
|
|
|
|
|
|
|
|||||||||||
Purchase accounting adjustments |
|
|
|
65 |
|
|
|
|
|
65 |
|
|
|
17 |
|
|
|
48 |
|
|
|
— |
||||
Transaction expenses |
|
|
|
|
|
(3,596 |
) |
|
|
3,596 |
|
|
|
939 |
|
|
|
2,657 |
|
|
|
0.02 |
||||
Change in fair value of derivatives |
|
|
|
|
|
|
|
2,429 |
|
|
|
634 |
|
|
|
1,795 |
|
|
|
0.02 |
||||||
Equity-based compensation |
|
|
|
96 |
|
|
|
(1,468 |
) |
|
|
1,564 |
|
|
|
400 |
|
|
|
1,164 |
|
|
|
0.01 |
||
Debt refinancing costs |
|
|
|
|
|
|
|
760 |
|
|
|
198 |
|
|
|
562 |
|
|
|
— |
||||||
Non-GAAP results |
$ |
103,488 |
|
$ |
55,463 |
|
|
$ |
22,611 |
|
|
$ |
38,813 |
|
|
$ |
7,453 |
|
|
$ |
21,143 |
|
|
$ |
0.18 |
|
Percentage of net sales |
|
|
|
53.6 |
% |
|
|
21.8 |
% |
|
|
37.5 |
% |
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Three months ended |
|||||||||||||||||||||||||
|
Net sales |
|
Gross profit |
|
SG&A |
|
Adjusted EBITDA |
|
Income tax |
|
Net income |
|
Diluted EPS |
|||||||||||||
GAAP results |
$ |
98,736 |
|
$ |
49,477 |
|
|
$ |
23,845 |
|
|
$ |
17,932 |
|
|
$ |
6,407 |
|
|
$ |
17,932 |
|
|
$ |
0.16 |
|
Percentage of net sales |
|
|
|
50.1 |
% |
|
|
24.2 |
% |
|
|
18.2 |
% |
|
|
|
|
|
|
|||||||
Interest expense |
|
|
|
|
|
|
|
1,636 |
|
|
|
|
|
|
|
|||||||||||
Income tax expense |
|
|
|
|
|
|
|
6,407 |
|
|
|
|
|
|
|
|||||||||||
Depreciation and amortization expense |
|
|
|
143 |
|
|
|
(1,933 |
) |
|
|
6,280 |
|
|
|
|
|
|
|
|||||||
EBITDA |
|
|
|
|
|
|
$ |
32,255 |
|
|
|
|
|
|
|
|||||||||||
Purchase accounting adjustments |
|
|
|
99 |
|
|
|
|
|
99 |
|
|
|
26 |
|
|
|
73 |
|
|
|
— |
||||
Transaction expenses |
|
|
|
|
|
(1,024 |
) |
|
|
1,024 |
|
|
|
267 |
|
|
|
757 |
|
|
|
0.01 |
||||
Change in fair value of derivatives |
|
|
|
|
|
|
|
(515 |
) |
|
|
(134 |
) |
|
|
(381 |
) |
|
|
— |
||||||
Equity-based compensation |
|
|
|
|
|
(1,199 |
) |
|
|
1,416 |
|
|
|
338 |
|
|
|
1,078 |
|
|
|
0.01 |
||||
Wildfire costs |
|
|
|
|
|
|
|
31 |
|
|
|
8 |
|
|
|
23 |
|
|
|
— |
||||||
Non-GAAP results |
$ |
98,736 |
|
$ |
49,719 |
|
|
$ |
19,689 |
|
|
$ |
34,310 |
|
|
$ |
6,912 |
|
|
$ |
19,482 |
|
|
$ |
0.17 |
|
Percentage of net sales |
|
|
|
50.4 |
% |
|
|
19.9 |
% |
|
|
34.7 |
% |
|
|
|
|
|
|
|||||||
Note: Sum of individual amounts may not recalculate due to rounding. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005758/en/
Investor Contact
ir@duckhorn.com
707-302-2635
Media Contact
DuckhornPR@icrinc.com
203-682-8200
Source:
FAQ
What were the key financial results for Duckhorn Portfolio in Q2 2023?
How did Duckhorn Portfolio's guidance for FY 2023 change?
What contributed to the increase in Duckhorn Portfolio's gross profit in Q2 2023?
What was Duckhorn Portfolio's gross profit margin for Q2 2023?